The 2024 CPOP Conference offered participating service providers the opportunity to hear news and matters of interest from the field.

Conference video recordings have been made publicly available with the express approval of all presenters.

Community Program for Opioid Pharmacotherapy (CPOP) Pharmacist Training is provided by the Community Pharmacotherapy Program for WA pharmacists dispensing methadone and buprenorphine within an established support program for the treatment of opioid dependence. The WA Medicines and Poisons Regulations require all pharmacists dispensing or administering CPOP treatment are appropriately trained in providing this service. This course is designed to meet the training requirements prescribed by the Regulations and should be completed by all WA Pharmacists providing methadone and buprenorphine to CPOP clients.

CPOP Buprenorphine Prescriber Training is provided by the Community Pharmacotherapy Program for WA medical and nurse practitioners to prescribe buprenorphine within an established support program for the treatment of opioid dependence under the Community Program for Opioid Pharmacotherapy (CPOP). Upon successful completion of this online training module a WA medical or nurse practitioner will gain authority to prescribe buprenorphine products (Subutex, Suboxone, Buvidal and Sublocade) to suitable patients in WA. Authorisation as a buprenorphine prescriber under CPOP is issued by the WA Department of Health. Prescribers operate within WA CPOP Policies and Procedures with support through the Community Pharmacotherapy Program.

This section contains the current policy and procedure documentation for the Community Program for Opioid Pharmacotherapy

These resources demonstrate the administration and regulatory requirements for approved sublingual buprenorphine formulations. See below for: links to the Australian Product Information and Consumer Medicine Information for comprehensive prescribing and administration requirements.

In Western Australia sublingual buprenorphine is dispensed through authorised pharmacies under the direction of a medical practitioner approved by WA Department of Health to prescribe as part of the Community Program for Opioid Pharmacotherapy (CPOP). Refer to the WA CPOP Policies, Procedures and Guidelines for comprehensive prescribing and dispensing requirements. 

For further clinical information on CPOP contact CPOP Advice and Support (CAS) on 9442 5042.

These videos and resources demonstrate how to administer the two different CPOP approved depot buprenorphine products and provide links to the Australian Product Information and Consumer Medicine Information.

In Western Australia depot buprenorphine can only be administered by an authorised health professional (i.e. medical practitioner, pharmacist or nurse) under the direction of a health professional (i.e. medical practitioner or nurse practitioner) who has approval from the WA Department of Health to prescribe depot buprenorphine products through the Community Program for Opioid Pharmacotherapy (CPOP). 

For further information on the appropriate administration of depot buprenorphine contact CPOP Advice and Support (CAS) on 9442 5042.